Impact of program scale and indirect effects on the cost-effectiveness of vaccination programs.
作者信息
Ibuka Yoko, Paltiel A David, Galvani Alison P
机构信息
Yale University School of Medicine, New Haven, CT, USA (YI, ADP, APG)
Hitotsubashi University, Tokyo, Japan (YI)
出版信息
Med Decis Making. 2012 May-Jun;32(3):442-6. doi: 10.1177/0272989X12441397. Epub 2012 Apr 3.
Abstract
摘要
相似文献
1
Impact of program scale and indirect effects on the cost-effectiveness of vaccination programs.
Med Decis Making. 2012 May-Jun;32(3):442-6. doi: 10.1177/0272989X12441397. Epub 2012 Apr 3.
2
[An economic evaluation of strategy for expanding influenza vaccination in Japan].
Nihon Rinsho. 2003 Nov;61(11):2013-8.
3
Modelling the optimal target age group for seasonal influenza vaccination in Japan.
Vaccine. 2020 Jan 22;38(4):752-762. doi: 10.1016/j.vaccine.2019.11.001. Epub 2019 Nov 15.
4
Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department.
JAMA Pediatr. 2018 Jan 2;172(1):e173879. doi: 10.1001/jamapediatrics.2017.3879.
5
Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea.
Pharmacoeconomics. 2018 Dec;36(12):1475-1490. doi: 10.1007/s40273-018-0715-5.
6
Cost-benefit analysis of a national influenza vaccination program in preventing hospitalisation costs in Australian adults aged 50-64 years old.
Vaccine. 2019 Sep 20;37(40):5979-5985. doi: 10.1016/j.vaccine.2019.08.028. Epub 2019 Aug 28.
7
The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
Vaccine. 2008 Apr 16;26(17):2142-53. doi: 10.1016/j.vaccine.2008.01.050. Epub 2008 Feb 20.
8
The cost-effectiveness of influenza vaccination in elderly Australians: an exploratory analysis of the vaccine efficacy required.
Vaccine. 2014 Mar 10;32(12):1323-5. doi: 10.1016/j.vaccine.2014.01.017. Epub 2014 Jan 28.
9
School-Based Influenza Vaccination: Health and Economic Impact of Maine's 2009 Influenza Vaccination Program.
Health Serv Res. 2017 Dec;52 Suppl 2(Suppl 2):2307-2330. doi: 10.1111/1475-6773.12786.
10
Cost effectiveness analysis of Year 2 of an elementary school-located influenza vaccination program-Results from a randomized controlled trial.
BMC Health Serv Res. 2015 Nov 16;15:511. doi: 10.1186/s12913-015-1169-5.
引用本文的文献
1
Cost-Effectiveness Analysis in Implementation Science: a Research Agenda and Call for Wider Application.
Curr HIV/AIDS Rep. 2021 Jun;18(3):176-185. doi: 10.1007/s11904-021-00550-5. Epub 2021 Mar 20.
2
Dynamic Models of Infectious Disease Transmission in Prisons and the General Population.
Epidemiol Rev. 2018 Jun 1;40(1):40-57. doi: 10.1093/epirev/mxx014.
3
Dengue dynamics and vaccine cost-effectiveness in Brazil.
Vaccine. 2013 Aug 20;31(37):3957-61. doi: 10.1016/j.vaccine.2013.06.036. Epub 2013 Jun 20.
本文引用的文献
1
From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination.
Vaccine. 2011 Mar 3;29(11):2149-58. doi: 10.1016/j.vaccine.2010.12.078. Epub 2011 Jan 6.
2
Estimating the cost-effectiveness of pneumococcal conjugate vaccination in Brazil.
Rev Panam Salud Publica. 2009 Dec;26(6):518-28. doi: 10.1590/s1020-49892009001200007.
3
Huge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar).
Vaccine. 2010 Mar 11;28(12):2367-9. doi: 10.1016/j.vaccine.2010.01.005. Epub 2010 Jan 17.
4
Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009.
Ann Intern Med. 2009 Dec 15;151(12):829-39. doi: 10.7326/0003-4819-151-12-200912150-00157.
5
Probabilistic indoor transmission modeling for influenza (sub)type viruses.
J Infect. 2010 Jan;60(1):26-35. doi: 10.1016/j.jinf.2009.09.015. Epub 2009 Oct 7.
6
Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic.
Health Econ. 2010 May;19(5):518-31. doi: 10.1002/hec.1485.
7
Cost-effectiveness analysis of a universal vaccination programme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in Sweden.
Scand J Infect Dis. 2008;40(9):721-9. doi: 10.1080/00365540802014872.
8
The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.
Clin Ther. 2008 Feb;30(2):341-57. doi: 10.1016/j.clinthera.2008.02.003.
9
Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches.
Pharmacoeconomics. 2008;26(3):191-215. doi: 10.2165/00019053-200826030-00004.
10
Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness.
Pharmacoeconomics. 2008;26(2):163-78. doi: 10.2165/00019053-200826020-00006.
Zotero 插件